Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Interest & Investment Income (2016 - 2019)

Tg Therapeutics (TGTX) has 4 years of Interest & Investment Income data on record, last reported at $1.7 million in Q2 2019.

  • For Q2 2019, Interest & Investment Income rose 800.53% year-over-year to $1.7 million; the TTM value through Jun 2019 reached $2.4 million, up 345.59%, while the annual FY2018 figure was $857000.0, 190.51% up from the prior year.
  • Interest & Investment Income reached $1.7 million in Q2 2019 per TGTX's latest filing, up from $149000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.7 million in Q2 2019 and bottomed at $45000.0 in Q1 2017.
  • Average Interest & Investment Income over 4 years is $237571.4, with a median of $106814.5 recorded in 2016.
  • Peak YoY movement for Interest & Investment Income: tumbled 46.97% in 2017, then soared 800.53% in 2019.
  • A 4-year view of Interest & Investment Income shows it stood at $57544.0 in 2016, then soared by 110.27% to $121000.0 in 2017, then soared by 119.83% to $266000.0 in 2018, then soared by 539.85% to $1.7 million in 2019.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were $1.7 million in Q2 2019, $149000.0 in Q1 2019, and $266000.0 in Q4 2018.